Coya Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.6M | $-7.2M | $-5.7M | $-2.1M | $-6.1M | $-7.3M | $-2.9M | $-4.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $2.8K | $2.8K | $6.8K | $6.8K | $6.8K | $6.8K | $6.8K | $6.8K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $943.9K | $2.2M | $1.1M | $1.1M | $1.0M | $1.1M | $790.5K | $775.0K |
| Net Cash from Operating Activities | $-7.4M | $-6.2M | $-1.0M | $-1.1M | $-5.8M | $-2.8M | $-2.4M | $-5.5M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.7K | $-885.0K | — | — | — | — | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-166.1K | $11.0M | $20.3M | $19.1K | $0 | $19.1K | $9.7M | $-56.3K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |